Results 71 to 80 of about 649,069 (245)

Increase in circulating GLP-1 following low FODMAP diet in irritable bowel syndrome patients

open access: yesFrontiers in Nutrition
BackgroundFermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) as well as glucagon-like peptide-1 (GLP-1) have independently been implicated in irritable bowel syndrome (IBS) pathophysiology.
Umael Khan   +15 more
doaj   +1 more source

Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain

open access: yesGastroenterology Research and Practice, 2016
Objectives. The aim of the study was to establish whether fecal calprotectin concentration (FCC) may be useful in children with chronic abdominal pain to differentiate between inflammatory bowel disease (IBD), other inflammatory gastrointestinal ...
Stanisław Pieczarkowski   +5 more
doaj   +1 more source

Personal relative deprivation associated with functional disorders via stress: An examination of fibromyalgia and gastrointestinal symptoms. [PDF]

open access: yesPLoS ONE, 2017
Personal relative deprivation is a negative social comparison process typified by self-comparison, negative appraisal, and resultant negative emotionality.
Shadi Beshai   +3 more
doaj   +1 more source

Time trend occurrence of duodenal intraepithelial lymphocytosis and celiac disease in an open access endoscopic population [PDF]

open access: yes, 2017
Background: Duodenal intraepithelial lymphocytosis (DIL) is a histological finding characterized by the increase of intraepithelial CD3T-lymphocytes over the normal value without villous atrophy, mostly associated to coeliac disease (CD), Helicobacter ...
Annibale, B.   +7 more
core   +2 more sources

Functional gastrointestinal disorders and gut-brain axis: What does the future hold?

open access: yesWorld Journal of Gastroenterology, 2019
Despite their high prevalence, lack of understanding of the exact pathophysiology of the functional gastrointestinal disorders has restricted us to symptomatic diagnostic tools and therapies.
Kashif Mukhtar, Hasham Nawaz, S. Abid
semanticscholar   +1 more source

Functional Gastrointestinal Disorders and the Microbiome: What is the best strategy for moving microbiome-based therapies for functional gastrointestinal disorders into the clinic?

open access: yesGastroenterology, 2020
There have been numerous human studies reporting associations between the intestinal microbiome and functional gastrointestinal disorders (FGIDs), and independently animal studies have explored microbiome-driven mechanisms underlying FGIDs.
R. Mars, M. Frith, P. Kashyap
semanticscholar   +1 more source

A 12-Week Strict Low FODMAP Diet Reduces the Severity Levels of Fatigue, Depression, Anxiety, and Inattention in Patients with Irritable Bowel Syndrome

open access: yesCurrent Developments in Nutrition
Background: The low FODMAP diet (LFD) has been shown to alleviate gastrointestinal symptoms in patients with irritable bowel syndrome (IBS). However, the impact of the LFD on coexisting symptoms of fatigue, anxiety, depression, and cognitive functions ...
Sol Maja G Bjørkevoll   +6 more
doaj   +1 more source

Neurovisceral phenotypes in the expression of psychiatric symptoms [PDF]

open access: yes, 2015
This review explores the proposal that vulnerability to psychological symptoms, particularly anxiety, originates in constitutional differences in the control of bodily state, exemplified by a set of conditions that include Joint Hypermobility, Postural ...
Aktas   +132 more
core   +2 more sources

Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders

open access: yesFrontiers in Psychiatry, 2020
Much has been written about the placebo effects in functional gastrointestinal disorders (FGD), especially in irritable bowel syndrome (IBS), driven by the early hypothesis that in randomized controlled trials (RCTs) of IBS, the placebo effect might be ...
P. Enck, S. Klosterhalfen
semanticscholar   +1 more source

S-Adenosyl-L-Methionine protects the probiotic yest, \u3cem\u3eSaccharomyces boulardii\u3c/em\u3e, from acid-induced cell death [PDF]

open access: yes, 2013
Background Saccharomyces boulardii is a probiotic yeast routinely used to prevent and to treat gastrointestinal disorders, including the antibiotic-associated diarrhea caused by Clostridium difficile infections.
Austriaco, Nicanor   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy